- Home
- IGC vs IZM Comparison
IGC vs IZM Comparison
Compare IGC & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IGC
- IZM
- Stock Information
- Founded
- IGC 2005
- IZM 2011
- Country
- IGC United States
- IZM China
- Employees
- IGC N/A
- IZM N/A
- Industry
- IGC Biotechnology: Pharmaceutical Preparations
- IZM Consumer Electronics/Video Chains
- Sector
- IGC Health Care
- IZM Consumer Discretionary
- Exchange
- IGC Nasdaq
- IZM Nasdaq
- Market Cap
- IGC 29.4M
- IZM 23.7M
- IPO Year
- IGC N/A
- IZM 2023
- Fundamental
- Price
- IGC $0.37
- IZM $1.83
- Analyst Decision
- IGC Strong Buy
- IZM
- Analyst Count
- IGC 2
- IZM 0
- Target Price
- IGC $3.75
- IZM N/A
- AVG Volume (30 Days)
- IGC 469.7K
- IZM 51.4K
- Earning Date
- IGC 02-12-2025
- IZM 01-07-2025
- Dividend Yield
- IGC N/A
- IZM N/A
- EPS Growth
- IGC N/A
- IZM N/A
- EPS
- IGC N/A
- IZM N/A
- Revenue
- IGC $1,183,000.00
- IZM $177,933,890.00
- Revenue This Year
- IGC N/A
- IZM N/A
- Revenue Next Year
- IGC $13.57
- IZM N/A
- P/E Ratio
- IGC N/A
- IZM N/A
- Revenue Growth
- IGC N/A
- IZM N/A
- 52 Week Low
- IGC $0.27
- IZM $1.80
- 52 Week High
- IGC $0.91
- IZM $52.21
- Technical
- Relative Strength Index (RSI)
- IGC 49.16
- IZM 27.40
- Support Level
- IGC $0.33
- IZM $1.98
- Resistance Level
- IGC $0.38
- IZM $2.11
- Average True Range (ATR)
- IGC 0.03
- IZM 0.10
- MACD
- IGC -0.00
- IZM -0.03
- Stochastic Oscillator
- IGC 44.44
- IZM 6.29
About IGC IGC Pharma Inc.
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.
About IZM ICZOOM Group Inc.
ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.